zolbetuximab
astellas,leap therapeutics,biontech
[]
clinicaltrials_gov shows most claudin18.2 mabs are being tested in biomarker+ve populations. here's key detail from $alpmy zolbetuximab trial presented last night at #gi23, via -&gt; $lptx $bntx
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.